Theratechnologies Inc. Gains 47.57%
Theratechnologies Inc. (THTX:NASDAQ) shot up at $1.52, representing a gain of 47.6%. On Wed, Sep 06, 2023, THTX:NASDAQ hit a New 2-Week High of $1.52. The stock got featured on our News Catalysts scanner on Wed, Sep 06, 2023 at 01:32 PM in the 'AGREEMENT' category. From Wed, Aug 23, 2023, the stock recorded 55.56% Up Days and 60.00% Green Days
About Theratechnologies Inc. (THTX:NASDAQ)
Theratechnologies Inc is a specialty pharmaceutical company which addresses unmet medical needs of HIV patients. The company mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Top 10 Gainers:
- Palisade Bio Inc. (PALI:NASDAQ), 108.73%
- NeuBase Therapeutics, Inc. (NBSE:NASDAQ), 106.96%
- Power REIT (PW:NYSEMKT), 55.12%
- Theratechnologies Inc. (THTX:NASDAQ), 47.57%
- Marin Software Incorporated (MRIN:NASDAQ), 45.49%
- Applied Therapeutics, Inc. (APLT:NASDAQ), 42.86%
- Greenland Technologies Holding Corporation (GTEC:NASDAQ), 30.26%
- FLJ Group Limited (FLJ:NASDAQ), 28.24%
- Cidara Therapeutics, Inc. (CDTX:NASDAQ), 26.07%
- Signature Bank (SBNY:NASDAQ), 25%